연구성과로 돌아가기
2021 연구성과별 연구자 정보 (741 / 2991)
※ 현재 Web of Science 저자 정보만 집계되어 있습니다.
※ 컨트롤 + 클릭으로 열별 다중 정렬 가능합니다.
Excel 다운로드
| Document Title | Author Full Name | Author Short Name | Index | Corresponding | Address | ResearcherID | ResearcherID Author Name | ORCID | ORCID Author Name | Related Email |
|---|---|---|---|---|---|---|---|---|---|---|
| Efficacy of two vaccines against recent emergent antigenic variants of clade 2.3.2.1a highly pathogenic avian influenza viruses in Bangladesh | Lee, Dong-Hun | Lee, DH | 10 | Univ Connecticut, Dept Pathobiol & Vet Sci, Storrs, CT 06269 USA | David.Swayne@USDA.GOV; | |||||
| Efficacy of two vaccines against recent emergent antigenic variants of clade 2.3.2.1a highly pathogenic avian influenza viruses in Bangladesh | Spackman, Erica | Spackman, E | 11 | ARS, USDA, US Natl Poultry Res Ctr, 934 Coll Stn Rd, Athens, GA 30605 USA | David.Swayne@USDA.GOV; | |||||
| Efficacy of two vaccines against recent emergent antigenic variants of clade 2.3.2.1a highly pathogenic avian influenza viruses in Bangladesh | Swayne, David E. | Swayne, DE | 12 | 교신저자 | ARS, USDA, US Natl Poultry Res Ctr, 934 Coll Stn Rd, Athens, GA 30605 USA | AAP-7166-2020 | Swayne, David | David.Swayne@USDA.GOV; | ||
| Efficacy, safety, and tolerability of seladelpar in patients with compensated liver cirrhosis due to primary biliary cholangitis (PBC): a pooled analysis of phase 2 and phase 3 studies | Gordon, Stuart C. | Gordon, SC | 1 | Henry Ford Hlth Syst, Detroit, MI USA | ychoi@cymabay.com; | |||||
| Efficacy, safety, and tolerability of seladelpar in patients with compensated liver cirrhosis due to primary biliary cholangitis (PBC): a pooled analysis of phase 2 and phase 3 studies | Trivedi, Palak | Trivedi, P | 2 | Univ Hosp Birmingham, Birmingham, W Midlands, England | ychoi@cymabay.com; | |||||
| Efficacy, safety, and tolerability of seladelpar in patients with compensated liver cirrhosis due to primary biliary cholangitis (PBC): a pooled analysis of phase 2 and phase 3 studies | Bowlus, Christopher | Bowlus, C | 3 | Univ Calif Davis, Med Ctr, Sacramento, CA 95817 USA | N-9276-2016 | Bowlus, Christopher | ychoi@cymabay.com; | |||
| Efficacy, safety, and tolerability of seladelpar in patients with compensated liver cirrhosis due to primary biliary cholangitis (PBC): a pooled analysis of phase 2 and phase 3 studies | Michael, Galambos | Michael, G | 4 | Digest Healthcare Georgia, Atlanta, GA USA | ychoi@cymabay.com; | |||||
| Efficacy, safety, and tolerability of seladelpar in patients with compensated liver cirrhosis due to primary biliary cholangitis (PBC): a pooled analysis of phase 2 and phase 3 studies | Goel, Aparna | Goel, A | 5 | Stanford Hosp, Stanford, CA USA | ychoi@cymabay.com; | |||||
| Efficacy, safety, and tolerability of seladelpar in patients with compensated liver cirrhosis due to primary biliary cholangitis (PBC): a pooled analysis of phase 2 and phase 3 studies | Gulamhusein, Aliya | Gulamhusein, A | 6 | Toronto Gen Hosp, Toronto, ON, Canada | ychoi@cymabay.com; | |||||
| Efficacy, safety, and tolerability of seladelpar in patients with compensated liver cirrhosis due to primary biliary cholangitis (PBC): a pooled analysis of phase 2 and phase 3 studies | Levy, Cynthia | Levy, C | 7 | Univ Miami, Miami, FL USA | ychoi@cymabay.com; | |||||
| Efficacy, safety, and tolerability of seladelpar in patients with compensated liver cirrhosis due to primary biliary cholangitis (PBC): a pooled analysis of phase 2 and phase 3 studies | Neff, Guy | Neff, G | 8 | Covenant Res, Sarasota, FL USA | ychoi@cymabay.com; | |||||
| Efficacy, safety, and tolerability of seladelpar in patients with compensated liver cirrhosis due to primary biliary cholangitis (PBC): a pooled analysis of phase 2 and phase 3 studies | Stanca, Carmen | Stanca, C | 9 | NYU Langone Hlth, New York, NY USA | ychoi@cymabay.com; | |||||
| Efficacy, safety, and tolerability of seladelpar in patients with compensated liver cirrhosis due to primary biliary cholangitis (PBC): a pooled analysis of phase 2 and phase 3 studies | Thorburn, Douglas | Thorburn, D | 10 | Royal Free Hosp, London, England | ychoi@cymabay.com; | |||||
| Efficacy, safety, and tolerability of seladelpar in patients with compensated liver cirrhosis due to primary biliary cholangitis (PBC): a pooled analysis of phase 2 and phase 3 studies | Bacon, Bruce | Bacon, B | 11 | St Louis Univ, Sch Med, St Louis, MO USA | AAD-6897-2021 | Simona, Gheorghe | ychoi@cymabay.com; | |||
| Efficacy, safety, and tolerability of seladelpar in patients with compensated liver cirrhosis due to primary biliary cholangitis (PBC): a pooled analysis of phase 2 and phase 3 studies | Borg, Brian | Borg, B | 12 | Jackson Liver & GI Specialists, Jackson, MS USA | A-5512-2011 | Borg, Brian | ychoi@cymabay.com; |
페이지 이동: